Pharmaceutical

AstraZeneca’s Truqap and Faslodex combo receives approval in EU

AstraZeneca has received approval for Truqap in combination with Faslodex in the EU to treat certain advanced breast cancer cases in adults.

Jun 22, 2024 - 04:00
AstraZeneca’s Truqap and Faslodex combo receives approval in EU
AstraZeneca has received approval for Truqap in combination with Faslodex in the EU to treat certain advanced breast cancer cases in adults.
Read the original article

Tags:

Previous Article

Sanofi and Biovac partner to produce polio vaccines in Africa

Next Article

Will WHO’s new guidance spur hepatitis B immunisation?

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Development and Manufacturing of Primary Packaging and ...

Apr 26, 2023

Meilleur partners with ADNI4 for next-generation Alzheimer’s biomarker

Meilleur partners with ADNI4 for next-generation Alzhei...

Oct 21, 2023

‘It’s a universal experience’: Doctor who treats Boston’s homeless population on why community is vital to health

‘It’s a universal experience’: Doctor who treats Boston...

Mar 24, 2023